MOLECULAR EXPRESS, INC
US UEI R1JMHFESEKD5 · SME
55public awards
$38.6Mtotal public funding
2026-04-28latest award
State aid awards (55)
| Date | Amount | Type | Programme | Granted by |
|---|---|---|---|---|
| 2026-04-28 | $2.0M | Grant | CARDIOVASCULAR DISEASES RESEARCH | Department of Health and Human Services |
| 2024-05-15 | $2.0M | Grant | Preclinical Development of a ME-1001, a Synthetic Lung Surfactant | Department of Health and Human Services |
| 2024-01-01 | $2.0M | Grant | DESIGN AND ENGINEERING OF VESIVAX HIV IMMUNOGEN FORMULATIONS | Department of Health and Human Services |
| 2024-01-01 | $3.0M | Grant | Development of a VesiVax TLR7 Formula as an Effective Adjuvant | Department of Health and Human Services |
| 2023-01-01 | $600k | Grant | DEVELOPMENT OF VESIVAX CO-ADJUVANT FORMULATION OF 2E151. | Department of Health and Human Services |
| 2022-07-08 | $298k | Grant | Niclosamide Formulations for the Treatment of Influenza Infections | Department of Health and Human Services |
| 2022-02-18 | $600k | Grant | VesiVax Vaccine Formulation Against Neisseria gonorrhoeae | Department of Health and Human Services |
| 2022-01-01 | $2.0M | Grant | Development of a VesiVax HIV Vaccine Formulation | Department of Health and Human Services |
| 2022-01-01 | $300k | Grant | VesiVax HIVgp41e Vaccine Design | Department of Health and Human Services |
| 2021-06-18 | $2.2M | Grant | Non-clinical Development of a Synthetic Lung Surfactant for Treatment | Department of Health and Human Services |
| 2021-01-01 | $300k | Grant | THE CONTRACTOR SHALL TO EVALUATE THE DIFFERENT CO-DELIVERY METHODS OF | Department of Health and Human Services |
| 2021-01-01 | $570k | Grant | DEVELOPMENT OF A VESIVAS IMMUNOSIMILAR FORMULATION | Department of Health and Human Services |
| 2020-01-01 | $300k | Grant | THE OBJECTIVE OF THIS CONTRACT IS TO IDENTIFY A POTENTIAL HIV ANTIGEN- | Department of Health and Human Services |
| 2020-01-01 | $300k | Grant | THE OBJECTIVE OF THIS CONTRACT IS TO DEVELOP A VESIVAX PLATFORM-BASED | Department of Health and Human Services |
| 2019-01-01 | $600k | Grant | Evaluation of VesiVax Adjuvant Formulations for HIV Vaccines | Department of Health and Human Services |
| 2018-01-01 | $214k | Grant | Contract Award for SBIR Topic 061 ""Mucosal Stimulatory VesiVax Vaccin | Department of Health and Human Services |
| 2017-07-01 | $1.4M | Grant | Development of a Vaccine for the Prevention of Pulmonary Aspergillosis | Department of Health and Human Services |
| 2017-02-07 | $300k | Grant | VesiVax Peanut Allergy Immunotherapy | Department of Health and Human Services |
| 2016-08-01 | $1.5M | Grant | The VesiVax System Vaccine Development Made Easy | Department of Health and Human Services |
| 2016-04-01 | $225k | Grant | Optimization of VesiVax® Lipidated Tucaresol Formulations | Department of Health and Human Services |
| 2015-09-01 | $225k | Grant | Pre-clinical Development of a Vaccine for the Treatment of Heroin Addi | Department of Health and Human Services |
| 2015-09-01 | $323k | Grant | Development of a Gene and Oligonucleotide Delivery System | Department of Health and Human Services |
| 2015-06-15 | $330k | Grant | Development of a Vaccine for the Prevention of Pulmonary Aspergillosis | Department of Health and Human Services |
| 2015-06-15 | $290k | Grant | Design and Engineering of Nanoparticulate Universal Vaccines | Department of Health and Human Services |
| 2014-01-01 | $246k | Grant | Engineering of a Novel CDN Nanoparticle Platform | Department of Health and Human Services |
| 2013-01-01 | $294k | Grant | A dual-nanopore platform for sensing and control of polynucleotides | Department of Health and Human Services |
| 2013-01-01 | $600k | Grant | Novel Hybrid Bioanalytical System | Department of Health and Human Services |
| 2012-01-01 | $600k | Grant | Targeted Dendritic Cell Activation through Multi-Adjuvant Liposomes | Department of Health and Human Services |
| 2012-01-01 | $3.0M | Grant | Development of a novel SP-B peptide lung surfactant | Department of Health and Human Services |
| 2012-01-01 | $402k | Grant | Formulation of TLR 3, 7, and 8 Agonists in Conjugatable Adjuvant Lipid | Department of Health and Human Services |
| 2011-01-01 | $345k | Grant | Liposomal Nicotine Vaccine Development | Department of Health and Human Services |
| 2011-01-01 | $198k | Grant | Not Available | Department of Health and Human Services |
| 2009-01-01 | $600k | Grant | Surrogate endpoints for correlating protective immunity in response to | Department of Health and Human Services |
| 2008-01-01 | $2.0M | Grant | Genital Herpes Vaccine Discovery | Department of Health and Human Services |
| 2008-01-01 | $300k | Grant | Liposomal Adjuvant for Vaccine Development | Department of Health and Human Services |
| 2008-01-01 | $300k | Grant | Thermal Targeting of Antimicrobial Drugs to Sites of Infection | Department of Health and Human Services |
| 2008-01-01 | $1.2M | Grant | Production of a Lung Surfactant SP-B Mimic | Department of Health and Human Services |
| 2008-01-01 | $362k | Grant | Virus Electrodes for Fungal Pathogen Detection | Department of Health and Human Services |
| 2007-01-01 | $250k | Grant | Development of a combination therapy for the treatment of prostate can | Department of Health and Human Services |
| 2007-01-01 | $300k | Grant | Development of an Aspergillus Vaccine | Department of Health and Human Services |
| 2007-01-01 | $249k | Grant | Liposomal Disintegrin: Novel and Effective Antitumor Agent Phase I | Department of Health and Human Services |
| 2006-01-01 | $1.3M | Grant | Aptamers for Imaging and Therapy | Department of Health and Human Services |
| 2006-01-01 | $336k | Grant | Selection and Characterization of PSMA Ligands from Phage-Displayed Li | Department of Health and Human Services |
| 2006-01-01 | $755k | Grant | Genital Herpes Vaccine Discovery | Department of Health and Human Services |
| 2005-11-11 | $730k | Grant | Repair, Regeneration, and Differentiation in Humans | Department of Defense |
| 2005-01-01 | $138k | Grant | Production of a Lung Surfactant SP-B Mimic | Department of Health and Human Services |
| 2004-12-07 | $120k | Grant | Repair, Regeneration, and Differentiation in Humans | Department of Defense |
| 2004-01-01 | $100k | Grant | Aptamers for Imaging and Therapy | Department of Health and Human Services |
| 2003-01-01 | $496k | Grant | Development of liposomal fenretinide and safingol | Department of Health and Human Services |
| 2003-01-01 | $886k | Grant | Universal Influenza Matrix 2 Subunit Vaccine | Department of Health and Human Services |
| 2002-01-01 | $132k | Grant | RAPID VACCINE DEVELOPMENT SYSTEM | Department of Health and Human Services |
| 2001-01-01 | $157k | Grant | TARGETED LIPOSOMAL DRUG DELIVERY TO LEUKEMIA CELLS | Department of Health and Human Services |
| 2000-01-01 | $100k | Grant | Not Available | Department of Health and Human Services |
| 1999-01-01 | $100k | Grant | LIPOSOMAL VACCINE ADJUVANT FOR INFLUENZA IMMUNIZATION | Department of Health and Human Services |
| 1998-01-01 | $100k | Grant | EVALUATION OF LIPOSOME BASED HERPES VACCINES | Department of Health and Human Services |
Want an alert when companies like this one get funded in your sector? Pro waitlist →